- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- April 2026
- 120 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- June 2026
- 200 Pages
Global
From €2717EUR$2,990USD£2,335GBP
- Report
- September 2026
- 185 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 181 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 182 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 182 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- January 2026
- 280 Pages
Global
From €3282EUR$3,613USD£2,822GBP
€3862EUR$4,250USD£3,320GBP
- Report
- June 2026
- 143 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 143 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- June 2026
- 296 Pages
Global
From €2272EUR$2,500USD£1,953GBP
- Report
- June 2026
- 312 Pages
Global
From €2272EUR$2,500USD£1,953GBP
- Report
- September 2026
- 384 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 578 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 172 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 372 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 184 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 382 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 392 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 224 Pages
Global
From €5316EUR$5,850USD£4,569GBP

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more